
Introduction to Bleeding Disorders
Adapted from: Global NMO Training 2016 plenary presentation by Glenn PierceReviewed by: Glenn PierceEdited by: Georghia Michael This first eLearning
Year: 2019
Language: English
Author(s): Mohamad A. Kalot Mohammed Al‐Khatib et al for the VWD Working Group
Format: Document
As part of their international collaboration to develop guidelines for the diagnosis and management of von Willebrand disease (VWD), the American Society of Hematology (ASH), the International Society on Thrombosis and Haemostasis (ISTH), the National Hemophilia Foundation (NHF) and the World Federation of Hemophilia (WFH), along with the guidelines methods team, conducted a stakeholder survey to identify topics of highest importance that could be addressed by the guidelines. This paper, freely available in Haemophilia Journal, the official journal of the WFH, shares the findings of this survey. A remarkable number of stakeholders participated in the survey from all over the world including people with VWD, their carers, hematologists, and other members of the comprehensive care team.

Adapted from: Global NMO Training 2016 plenary presentation by Glenn PierceReviewed by: Glenn PierceEdited by: Georghia Michael This first eLearning

In the Wednesday afternoon session on von Willebrand disease (VWD) Jeroen C.J. Eikenboom explains the diagnosis of von Wilebrand Disease

In the Sunday afternoon joint Laboratory Sciences and VWD Professional Development Workshop, Andra H. James explains the unique issues in

In the Sunday afternoon joint Laboratory Sciences and VWD Professional Development Workshop, Imre Bodó, explores new von Willebrand factor (VWF)

In the Wednesday afternoon session on von Willebrand disease (VWD), Augusto B. Federici provides a 2016 update on the management

Offers a detailed review of the basic science, clinical features, and classification of the various forms of von Willebrand Disease,